Format

Send to

Choose Destination
Breast Cancer. 2011 Jan;18(1):64-7. doi: 10.1007/s12282-010-0198-5. Epub 2010 Mar 31.

Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach.

Author information

1
Department of Breast Surgery, Graduate School of Medicine, Kyoto University, 54 Kawaracho, Shogoin, Sakyo-ku, Kyoto, Japan.

Abstract

A suggestive case of metastatic disease from breast cancer is reported. The HER-2-positive tumor was refractory to several agents, including anti-HER-2 therapy, trastuzumab, and lapatinib. After re-induction of trastuzumab in combination with activated natural killer (NK) cell injection therapy, tumor markers decreased, and finally a synergistic effect of taxane and capecitabine led to treatment response. This case suggests that multidisciplinary therapy including an immunological approach might be a breakthrough in the treatment of refractory disease.

PMID:
20354831
DOI:
10.1007/s12282-010-0198-5
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Springer Icon for Kyoto University Research Information Repository - Articles
Loading ...
Support Center